Los Altos, CA, United States of America

Tara Mirzadegan


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tara Mirzadegan: Innovator in Prostaglandin Analogues

Introduction

Tara Mirzadegan is a prominent inventor based in Los Altos, California. She has made significant contributions to the field of pharmaceuticals, particularly in the development of prostaglandin analogues. Her innovative work has led to advancements in therapeutic agents that can benefit various medical conditions.

Latest Patents

Tara Mirzadegan holds a patent for her invention titled "8-aza-11-deoxy prostaglandin analogues." This invention relates to compounds that act as EPreceptor agonists, represented by a specific formula. The compounds include various substituents and can exist as individual isomers, racemic or non-racemic mixtures, or pharmaceutically acceptable salts or solvates. The invention also encompasses pharmaceutical compositions containing these compounds, methods for their therapeutic use, and methods of preparation.

Career Highlights

Tara has worked with Syntex (U.S.A.) Inc., where she has been able to apply her expertise in pharmaceutical innovation. Her work has been instrumental in advancing the understanding and application of prostaglandin analogues in medicine.

Collaborations

Throughout her career, Tara has collaborated with notable colleagues, including Todd Richard Elworthy and Michael G. Roepel. These collaborations have contributed to the success of her projects and the development of new therapeutic solutions.

Conclusion

Tara Mirzadegan is a remarkable inventor whose work in prostaglandin analogues has the potential to impact the pharmaceutical industry significantly. Her dedication to innovation and collaboration continues to drive advancements in therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…